Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACLY | P53396 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4718820 | 0.86 | — | — | |
| SCHEMBL5752259 | 0.86 | IDO1 (0.32) | — | |
| SCHEMBL5778918 | 0.77 | CYP17A1 (0.32) | — | |
| SCHEMBL4718003 | 0.74 | TP53 (0.35) | — | |
| SCHEMBL5748131 | 0.74 | CDC7 (0.34) | — | |
| SCHEMBL4720814 | 0.74 | — | — | |
| SCHEMBL5751634 | 0.73 | GRM5 (0.35) | — | |
| SCHEMBL5751918 | 0.73 | MAPT (0.37) | — | |
| SCHEMBL4720835 | 0.66 | TP53 (0.31) | — | |
| SCHEMBL4715968 | 0.66 | CYP1A2 (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060160811-A1 | Aryl-condensed 3-arylpridine compounds and use thereof for controlling pathogenic fungi | BASF AKTIENGESELLSCHAFT (DE) | 2006-07-20 | — | — | US | disclosed |
| EP-1648890-A2 | ARYL-CONDENSED 3-ARYLPYRIDINE COMPOUNDS AND USE THEREOF FOR CONTROLLING PATHOGENIC FUNGI | BASF AKTIENGESELLSCHAFT (DE) | 2006-04-26 | — | — | EP | disclosed |
| WO-2005010000-A2 | ARYL-CONDENSED 3-ARYLPYRIDINE COMPOUNDS AND USE THEREOF FOR CONTROLLING PATHOGENIC FUNGI | BASF AKTIENGESELLSCHAFT (DE) | 2005-02-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060160811-A1 | Aryl-condensed 3-arylpridine compounds and use thereof for controlling pathogenic fungi | CBR3, C1R, CBR1 | ACLY 1769/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.